TH85621B - Hemero Aryl Ethyl Ethyl Derivatives, Production and Uses as Pharmaceutical Agents of the Substance - Google Patents
Hemero Aryl Ethyl Ethyl Derivatives, Production and Uses as Pharmaceutical Agents of the SubstanceInfo
- Publication number
- TH85621B TH85621B TH601003190A TH0601003190A TH85621B TH 85621 B TH85621 B TH 85621B TH 601003190 A TH601003190 A TH 601003190A TH 0601003190 A TH0601003190 A TH 0601003190A TH 85621 B TH85621 B TH 85621B
- Authority
- TH
- Thailand
- Prior art keywords
- ethyl
- substance
- production
- hemero
- pharmaceutical agents
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 206010011703 Cyanosis Diseases 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Abstract
วัตถุประสงค์ของการประดิษฐ์ปัจจุบันคือสารประกอบของสูตร I (สูตรเคมี) สูตร I เกลือซึ่งเป็นที่ยอมรับทางเภสัชกรรมของสารนั้น, รูปอีแนนทิโอเมอร์, ไดเอสเทอริโอเมอร์ และเรซีเมต, การเตรียมสารประกอบข้างต้น, ตัวยาสำคัญที่ประกอบด้วยสารเหล่านั้น และการผลิต สารเหล่านั้น เช่นเดียวกับวิธีการใช้สารประกอบข้างต้นในการควบคุมหรือการป้องกันภาวะเจ็บป่วย เช่น มะเร็ง The purpose of the present invention is a compound of formula I (chemical formula), formula I, a chemically acceptable salt of that substance, form enanthiomers, diastomeromers and resymates. , The preparations of the above compounds, the active ingredients that contain them and their production, as well as the methods for using the above compounds to control or prevent illnesses such as cancer.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH85621A TH85621A (en) | 2007-07-09 |
| TH85621B true TH85621B (en) | 2007-07-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201200938A1 (en) | IMIDAZOPIRIDINE DERIVATIVES AS JAK INHIBITORS | |
| NO20071901L (en) | Substituted bicyclic imidazo-3-ylamine compositions | |
| NO20090295L (en) | Substituted heteroaryl derivatives | |
| EA201201677A1 (en) | DERIVATIVES OF HETEROARILIMIDAZOLONE AS JAK INHIBITORS | |
| CY1117330T1 (en) | Benzodioxinyl Substituted Indazolium Derivatives | |
| ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
| EA201001205A1 (en) | COMPOUNDS CONTAINING CYCLOBUTOXY GROUP | |
| NO20075749L (en) | 1H-Quinazoline-2,4-diones and their use as ampa receptor ligands | |
| CY1114932T1 (en) | ANTIPARASSIAN FACTORS | |
| NO20085107L (en) | Spirocyclic nitriles as protease inhibitors | |
| BRPI0408353A (en) | compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound | |
| EA200601065A1 (en) | DERIVATIVES OF IMIDAZOL, METHODS OF THEIR PRODUCTION AND APPLICATION | |
| SE0400850D0 (en) | Novel Compounds | |
| EA201001855A1 (en) | COMPOUNDS CONTAINING CYCLOBUTOXY GROUP | |
| ATE482933T1 (en) | SULFOPYRROL DERIVATIVES | |
| NO20080553L (en) | Azinyl-3-sulfonylindazole derivatives as 5-hydroxytrypyamine-6 ligands | |
| NO20080937L (en) | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands | |
| DK1970372T3 (en) | Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-deoxy-polyols | |
| WO2009021957A3 (en) | Tricyclic heterocyclic compounds as gaba a modulators | |
| DE602007010038D1 (en) | Pyrimidine derivatives as protein kinininhibitors | |
| TH90405B (en) | Isokinoline aminopyrazole derivatives, the production of those substances. And use as a substance in pharmaceutical | |
| TH72407A (en) | Novel aniline derivatives, the production of these derivatives and their use in pharmaceuticals. | |
| TH94702B (en) | Antiviral compounds | |
| EA200970710A1 (en) | DERIVATIVES 2-PIPERAZIN-1-IL-3H-IMIDAZO [4,5-b] Pyridine | |
| TH81375B (en) | New compound |